东阳光药业通过IPO备案:年营收40亿 期内利润同比降98%

雷递网
21 Jun

雷递网 雷建平 6月21日广东东阳光药业股份有限公司(简称:“东阳光药业”)日前更新招股书,准备在港交所上市。年营收40亿 期内利润同比降98%东阳光药业是一家综合性制药公司,从事药物的研发、生产和商业化,专注于创新药,亦涉及改良型新药、仿制药和生物类似药。截至最后实际可行日期,东阳光药业在不同国家及地区(包括中国、美国及欧洲)拥有150款获批药物。东阳光药业于中国及境外市场销售48种及23种药品...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10